Results 21 to 30 of about 1,718,006 (300)

Endocrine Pancreatic Tumors [PDF]

open access: yesScandinavian Journal of Surgery, 2004
Neuroendocrine tumors of the pancreas are rare neoplasms that may arise sporadically or in association with a hereditary endocrine neoplasia syndrome. Effective management requires directed biochemical testing, careful choice of preoperative imaging tests, and complete pancreatic exploration by an experienced endocrine surgeon utilizing intraoperative ...
T C, Lairmore, J F, Moley
openaire   +2 more sources

Identification of pancreatic cancer invasion-related proteins by proteomic analysis [PDF]

open access: yes, 2009
Background – Markers of pancreatic cancer invasion were investigated in two clonal populations of the cell line, MiaPaCa-2, Clone #3 (high invasion) and Clone #8 (low invasion) using proteomic profiling of an in vitro model of pancreatic cancer ...
Naomi Walsh   +21 more
core   +2 more sources

In vivo total or partial hepatectomy followed by ex vivo liver resection and autotransplantation for malignant tumors: a single center experience

open access: yesFrontiers in Oncology, 2023
BackgroundEx vivo liver resection and autotransplantation (ELRAT) may provide an opportunity for R0 resection of conventionally unresectable hepatobiliary cancers and hepatic metastases.
Shaoyan Xu   +14 more
doaj   +1 more source

Gemcitabine: Progress in the treatment of pancreatic cancer [PDF]

open access: yes, 2001
Unresectable pancreatic cancer has a dismal prognosis with a median survival of 3-5 months in untreated disease. Since the introduction of gemcitabine, pancreatic cancer may no longer be regarded a chemotherapy-resistant tumor.
Heinemann, Volker
core   +1 more source

Pancreatic endocrine tumors [PDF]

open access: yesModern Pathology, 2011
The endocrine cells of the pancreas and their related cells throughout the gastrointestinal tract give rise to a variety of tumors that pose a diagnostic challenge. There has been progress in understanding their histogenesis, morphology, immunohistochemistry, molecular biology and classifications.
openaire   +4 more sources

Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer [PDF]

open access: yes, 2007
Tumor angiogenesis is a process that requires migration, proliferation, and differentiation of endothelial cells. We hypothesized that decrease in pancreatic tumor growth due to inhibition of src activity is associated with the inability of src kinase to
Ischenko, Ivan
core   +1 more source

Intratumoral and peritumoral radiomics model based on abdominal ultrasound for predicting Ki-67 expression in patients with hepatocellular cancer

open access: yesFrontiers in Oncology, 2023
BackgroundHepatocellular cancer (HCC) is one of the most common tumors worldwide, and Ki-67 is highly important in the assessment of HCC. Our study aimed to evaluate the value of ultrasound radiomics based on intratumoral and peritumoral tissues in ...
Hongwei Qian   +6 more
doaj   +1 more source

A systematic pan-cancer analysis of PXDN as a potential target for clinical diagnosis and treatment

open access: yesFrontiers in Oncology, 2022
Peroxidasin (PXDN), also known as vascular peroxidase-1, is a newly discovered heme-containing peroxidase; it is involved in the formation of extracellular mesenchyme, and it catalyzes various substrate oxidation reactions in humans.
Xiaohu Zhou   +14 more
doaj   +1 more source

CUL4B, NEDD4, and UGT1As involve in the TGF-β signalling in hepatocellular carcinoma

open access: yesAnnals of Hepatology, 2016
Introduction and Aim. TGF-β signalling is involved in pathogenesis and progress of hepatocellular carcinoma (HCC). This bioinformatics study consequently aims to determine the underlying molecular mechanism of TGF-β activation in HCC cells.Material and ...
Zhaowei Qu   +7 more
doaj   +1 more source

Pancreatic endocrine tumors

open access: yesJournal of Surgical Research, 2004
In 1902, Nicholls described a tumor originating from a pancreatic islet cell lineage [1]. This was the first report of a pancreatic endocrine tumor (PET). These uncommon tumors occur in approximately 1 out of 100,000 people [2–4]. The incidence in autopsy studies is as high as 1.5% [5].
John C, Mansour, Herbert, Chen
openaire   +5 more sources

Home - About - Disclaimer - Privacy